Garching, Germany
PreciPoint, founded in 2018 and headquartered in Germany, specializes in delivering comprehensive solutions for digitizing pathology workflows, thereby enhancing cancer diagnostics, research, and education. The company's slogan is "Comprehensive solutions for digitizing pathology workflows, and enhancing cancer diagnostics, research, and education."
As a leading international brand that is ISO 13485:2016-certified, PreciPoint emphasizes innovation, precision, and quality, adhering to high standards of German engineering. They offer advanced microscope systems, automated test systems, and software for image management and analysis, focusing on efficiency and accuracy in digital pathology.
Their flagship product, iO:M8, proves particularly valuable for intraoperative viewing during surgical procedures. The company secured a €10.00M Series A investment on 01 July 2022 from bm-t Beteiligungsmanagement Thüringen, positioning it for further growth in digital pathology solutions.
